Neurodevelopmental Impact of Maternal Immune Activation and Autoimmune Disorders, Environmental Toxicants and Folate Metabolism on Autism Spectrum Disorder
Author:
Open Access
- 4 September 2025
- journal article
- review article
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 47 (9) , 721
Abstract
Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition characterized by deficits in social communication, repetitive behaviors, and sensory sensitivities. While genetic factors contribute significantly to ASD risk, a growing body of evidence implicates environmental exposures and immune-mediated mechanisms in the etiology and severity of ASD. This review synthesizes peer-reviewed findings on (1) maternal immune activation, (2) environmental toxicant co-exposures, (3) maternal autoimmune disease, and (4) cerebral folate deficiency (via folate receptor alpha autoantibodies), detailing their mechanistic contributions to core and associated ASD symptoms. Collectively, these findings illuminate converging neuroimmune and metabolic pathways that, when disrupted in utero, substantially alter the developmental trajectory of the brain and increase the likelihood of ASD. Such interruptions leading to developmental changes can trigger immune activation from environmental sources of infection and pollution, with these triggers compounded in cases of autoimmune disease or cerebral folate deficiency. Understanding these mechanisms provides a foundation for early identification, stratified risk assessment, and the development of targeted prenatal interventions. Thus, a lesson we learn from autism is that neurodevelopmental disorders should be understood as the product of combined genetic vulnerabilities and modifiable prenatal and postnatal influences. Further exploration of this framework will open paths for precision intervention and prevention.Keywords
This publication has 76 references indexed in Scilit:
- Influenza With and Without Oseltamivir Treatment and Neuropsychiatric Events Among Children and AdolescentsJAMA Neurology, 2025
- Targeting the P2X7 receptor signaling pathway: Unlocking therapeutic strategies for autism spectrum disorderBrain, Behavior, & Immunity - Health, 2025
- Analysis of the Association Between the SLC19A1 Genetic Variant (rs1051266) and Autism Spectrum Disorders, Cerebral Folate Deficiency, and Clinical and Laboratory ParametersJournal of Molecular Neuroscience, 2025
- Exposure to polystyrene nanoplastics causes anxiety and depressive-like behavior and down-regulates EAAT2 expression in miceArchives of Toxicology, 2025
- Maternal Immune Activation and Autism in Offspring: What Is the Evidence for Causation?Biological Psychiatry, 2024
- RETRACTED ARTICLE: Efficacy of oral folinic acid supplementation in children with autism spectrum disorder: a randomized double-blind, placebo-controlled trialEuropean Journal of Pediatrics, 2024
- The Impact of Maternal Inflammatory Conditions During Pregnancy on the Risk of Autism: Methodological ChallengesBiological Psychiatry Global Open Science, 2024
- Serum binding folate receptor autoantibodies lower in autistic boys and positively-correlated with folateBiomedicine & Pharmacotherapy, 2024
- Folinic acid improves the score of Autism in the EFFET placebo-controlled randomized trialBiochimie, 2020
- Maternal Immune Activation and Autism Spectrum Disorder: From Rodents to Nonhuman and Human PrimatesBiological Psychiatry, 2017